logo
#

Latest news with #CHF88.00

Analysts Offer Insights on Technology Companies: Logitech (LOGI) and Infineon Technologies AG (OtherIFNNF)
Analysts Offer Insights on Technology Companies: Logitech (LOGI) and Infineon Technologies AG (OtherIFNNF)

Business Insider

time23-05-2025

  • Business
  • Business Insider

Analysts Offer Insights on Technology Companies: Logitech (LOGI) and Infineon Technologies AG (OtherIFNNF)

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Logitech (LOGI – Research Report) and Infineon Technologies AG (IFNNF – Research Report) with bullish sentiments. Confident Investing Starts Here: Logitech (LOGI) In a report issued on May 21, Torsten Sauter from Kepler Capital maintained a Buy rating on Logitech, with a price target of CHF88.00. The company's shares closed last Thursday at $86.54. According to Sauter is ranked #2232 out of 9559 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Logitech with a $87.23 average price target, a 1.5% upside from current levels. In a report issued on May 7, UBS also upgraded the stock to Buy with a CHF80.00 price target. In a report issued on May 21, Sebastien Sztabowicz from Kepler Capital maintained a Buy rating on Infineon Technologies AG, with a price target of EUR42.00. The company's shares closed last Thursday at $39.05. According to Sztabowicz has 0 stars on 0-5 stars ranking scale with an average return of -4.7% and a 42.7% success rate. Sztabowicz covers the Technology sector, focusing on stocks such as Telefonaktiebolaget LM Ericsson, ams-OSRAM, and Adyen. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Infineon Technologies AG with a $44.83 average price target, implying a 14.8% upside from current levels. In a report issued on May 7, Bank of America Securities also maintained a Buy rating on the stock with a EUR45.00 price target.

Analysts' Opinions Are Mixed on These Technology Stocks: Logitech (LOGI) and Eutelsat Communications (OtherEUTLF)
Analysts' Opinions Are Mixed on These Technology Stocks: Logitech (LOGI) and Eutelsat Communications (OtherEUTLF)

Business Insider

time17-05-2025

  • Business
  • Business Insider

Analysts' Opinions Are Mixed on These Technology Stocks: Logitech (LOGI) and Eutelsat Communications (OtherEUTLF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Logitech (LOGI – Research Report) and Eutelsat Communications (EUTLF – Research Report). Confident Investing Starts Here: Logitech (LOGI) Kepler Capital analyst Torsten Sauter maintained a Buy rating on Logitech on May 15 and set a price target of CHF88.00. The company's shares closed last Friday at $86.55. According to Sauter is ranked #2329 out of 9558 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Logitech with a $85.46 average price target, representing a -0.9% downside. In a report issued on May 7, UBS also upgraded the stock to Buy with a CHF80.00 price target. In a report issued on May 15, Alessandro Cuglietta from Kepler Capital maintained a Sell rating on Eutelsat Communications, with a price target of EUR2.40. The company's shares closed last Friday at $4.35.

Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Innate Pharma SA (OtherIPHYF)
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Innate Pharma SA (OtherIPHYF)

Business Insider

time15-05-2025

  • Business
  • Business Insider

Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Innate Pharma SA (OtherIPHYF)

Analysts fell to the sidelines weighing in on Alcon (ALC – Research Report) and Innate Pharma SA (IPHYF – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Confident Investing Starts Here: Alcon (ALC) Kepler Capital analyst Maja Pataki maintained a Hold rating on Alcon on May 13 and set a price target of CHF88.00. The company's shares closed last Wednesday at $87.24. According to Pataki has 0 stars on 0-5 stars ranking scale with an average return of -13.6% and a 33.6% success rate. Pataki covers the Healthcare sector, focusing on stocks such as Tecan Group AG, Demant, and Qiagen. Currently, the analyst consensus on Alcon is a Strong Buy with an average price target of $110.11. Innate Pharma SA (IPHYF) Kepler Capital analyst Justine Telliez maintained a Hold rating on Innate Pharma SA on May 13 and set a price target of EUR3.10. The company's shares closed last Friday at $1.45, close to its 52-week low of $1.28.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store